Search by Drug Name or NDC
NDC 66794-0202-42 Glycopyrrolate 0.2 mg/mL Details
Glycopyrrolate 0.2 mg/mL
Glycopyrrolate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Piramal Critical Care Inc. The primary component is GLYCOPYRROLATE.
Product Information
| NDC | 66794-0202 |
|---|---|
| Product ID | 66794-202_0d08c1e8-2cc3-33a5-e063-6394a90aa286 |
| Associated GPIs | 49102030002010 |
| GCN Sequence Number | 004886 |
| GCN Sequence Number Description | glycopyrrolate VIAL 0.2 MG/ML INJECTION |
| HIC3 | J2B |
| HIC3 Description | ANTICHOLINERGICS,QUATERNARY AMMONIUM |
| GCN | 19121 |
| HICL Sequence Number | 002028 |
| HICL Sequence Number Description | GLYCOPYRROLATE |
| Brand/Generic | Generic |
| Proprietary Name | Glycopyrrolate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Glycopyrrolate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 0.2 |
| Active Ingredient Units | mg/mL |
| Substance Name | GLYCOPYRROLATE |
| Labeler Name | Piramal Critical Care Inc |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210842 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66794-0202-42 (66794020242)
| NDC Package Code | 66794-202-42 |
|---|---|
| Billing NDC | 66794020242 |
| Package | 25 VIAL, GLASS in 1 CARTON (66794-202-42) / 1 mL in 1 VIAL, GLASS (66794-202-02) |
| Marketing Start Date | 2019-07-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |